These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 314587)

  • 1. Familial abnormalities of suppressor-cell function in systemic lupus erythematosus.
    Miller KB; Schwartz RS
    N Engl J Med; 1979 Oct; 301(15):803-9. PubMed ID: 314587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial alterations of immunoregulation in systemic lupus erythematosus.
    Spencer-Green G; Adams LE; Hurtubise P; Kravatz G; Hess EV
    J Rheumatol; 1985 Jun; 12(3):498-503. PubMed ID: 2931520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal T cell regulation of IgG synthesis in systemic lupus erythematosus.
    Nies KM; Stevens RH; Louie JS
    J Clin Lab Immunol; 1980 Sep; 4(2):69-75. PubMed ID: 6449594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
    Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
    J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [No correlation between suppressor cell function and disease activity in natural history studies of patients with systemic lupus erythematosus].
    Rautenstrauch H; Frank F; Saal JG
    Z Rheumatol; 1985; 44(3):133-6. PubMed ID: 2932868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD; Krakauer RA; Frank SA; Calabrese LH
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocyte hyperactivity in families of patients with systemic lupus erythematosus.
    Clark J; Bourne T; Salaman MR; Seifert MH; Isenberg DA
    J Autoimmun; 1996 Feb; 9(1):59-65. PubMed ID: 8845055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor T cells in systemic lupus erythematosus: lack of defective in vitro suppressor cell generation in patients with active disease.
    Tsokos GC; Balow JE
    J Clin Lab Immunol; 1982 Jun; 8(2):83-90. PubMed ID: 6213778
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
    Sagawa A; Abdou NI
    J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus.
    Scheinberg MA; Cathcart ES
    Clin Exp Immunol; 1976 May; 24(2):317-22. PubMed ID: 1084243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of antigen specific T cell helper function in first degree relatives of patients with systemic lupus erythematosus (SLE).
    Segal R; Brautbar C; Katz D; Shalev Y; Bentwich Z; Mozes E
    Clin Exp Immunol; 1986 Oct; 66(1):52-60. PubMed ID: 2433083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
    Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
    J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.